We are live on ! Find out more
BIO icon

Bio-Rad Laboratories Class A
BIO

236 hedge funds and large institutions have $2.74B invested in Bio-Rad Laboratories Class A in 2016 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 85 increasing their positions, 83 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

4,566% more call options, than puts

Call options by funds: $2.85M | Put options by funds: $61K

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

39% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 18

8% more capital invested

Capital invested by funds: $2.53B → $2.74B (+$203M)

1.81% more ownership

Funds ownership: 76.97% → 78.78% (+1.8%)

2% more funds holding

Funds holding: 232 → 236 (+4)

2% more repeat investments, than reductions

Existing positions increased: 85 | Existing positions reduced: 83

Holders
236
Holders Change
+4
Holders Change %
+1.72%
% of All Funds
6.3%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
25
Increased
85
Reduced
83
Closed
18
Calls
$2.85M
Puts
$61K
Net Calls
+$2.79M
Net Calls Change
-$2.53M

Top Buyers

Rank Fund Capital Flow
1
CM
Corvex Management
New York
+$69.5M
2
Morgan Stanley
Morgan Stanley
New York
+$21M
3
CS
Credit Suisse
Switzerland
+$20.7M
4
NIMC
NWQ Investment Management Company
California
+$11.5M
5
EAM
EverPoint Asset Management
Connecticut
+$9.98M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$14.8M
2
Renaissance Technologies
Renaissance Technologies
New York
-$13.9M
3
BNP Paribas Financial Markets
BNP Paribas Financial Markets
France
-$10.3M
4
GAM
Gotham Asset Management
New York
-$9.26M
5
BG
BlackRock Group
United Kingdom
-$7.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
O
176
OppenheimerFunds
New York
$294K -$4.56K -32 -2%
OAM
177
Oxford Asset Management
United Kingdom
$281K +$280K +1,962 New
CMBA
178
C.M. Bidwell & Associates
Hawaii
$277K +$276K +1,935 New
M&T Bank
179
M&T Bank
New York
$268K +$713 +5 +0.3%
MAM
180
Meeder Asset Management
Ohio
$266K +$102K +716 +63%
CT
181
Chicago Trust
Illinois
$260K – – –
BCM
182
Breithorn Capital Management
New York
$257K – – –
Pacer Advisors
183
Pacer Advisors
Pennsylvania
$254K +$253K +1,773 New
HI
184
HBK Investments
Texas
$240K -$223K -1,566 -48%
FLAM
185
First Light Asset Management
Minnesota
$240K – – –
HNB
186
Huntington National Bank
Ohio
$239K -$102K -718 -30%
RCM
187
Riverhead Capital Management
Delaware
$233K -$285K -1,998 -55%
SCA
188
Secor Capital Advisors
New York
$224K +$223K +1,561 New
VKH
189
Virtu KCG Holdings
New York
$210K -$117K -820 -36%
LSCM
190
LaSalle Street Capital Management
Illinois
$207K +$206K +1,445 New
LIA
191
LS Investment Advisors
Michigan
$199K +$81.6K +572 +70%
GT
192
Glenmede Trust
Pennsylvania
$186K – – –
GS
193
GAM Systematic
United Kingdom
$186K +$77.6K +544 +72%
PAM
194
Panagora Asset Management
Massachusetts
$171K -$74.9K -525 -31%
PG
195
PEAK6 Group
Illinois
$164K -$76.5K -536 -32%
Barclays
196
Barclays
United Kingdom
$149K +$54.8K +384 +57%
Creative Planning
197
Creative Planning
Kansas
$126K – – –
CAL
198
Capital Analysts LLC
Pennsylvania
$117K – – –
AG
199
Advisor Group
Arizona
$108K +$109K +766 New
AAM
200
Advisors Asset Management
Colorado
$105K +$19.1K +134 +22%
6 7
8
9 10

BIO Hedge Fund Activity: Q2 2016 in Review

236 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Bio-Rad Laboratories Class A (BIO) for Q2 2016, worth a combined $2.74B — up 8% from $2.53B a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new BIO positions and 18 closed out — a net gain of 7 holders — while 85 added to existing stakes and 83 trimmed.

The largest buyer was Corvex Management, opening a new position worth an estimated $69.5M. The largest seller was BlackRock Advisors, cutting an estimated $14.8M.

  • 236 institutional investors held Bio-Rad Laboratories Class A (BIO) as of Q2 2016, up from 232 in Q1 2016.
  • Funds reported $2.74B of Bio-Rad Laboratories Class A stock for Q2 2016, up 8% quarter-over-quarter.
  • 25 funds opened new Bio-Rad Laboratories Class A positions in Q2 2016 and 18 closed out, a net change of +7 holders.
  • The largest Bio-Rad Laboratories Class A buyer in Q2 2016 was Corvex Management, an estimated $69.5M added.
  • The largest Bio-Rad Laboratories Class A seller in Q2 2016 was BlackRock Advisors, an estimated $14.8M sold.

Based on aggregated 13F filings for Q2 2016.